b-Arrestins in the Immune System - Progress in Molecular Biology and Translational Science - page 376

38. Bari R, Bell T, Leung WH, et al. Significant functional heterogeneity among
KIR2DL1 alleles and a pivotal role of arginine 245. Blood . 2009;114:5182- 5190.
39. Jacob C, Yang PC, Darmoul D, et al. Mast cell tryptase controls paracellular perme-
ability of the intestine. Role of protease-activated receptor 2 and beta-arrestins.
J Biol Chem . 2005;280:31936- 31948.
40. Wagner E, Frank MM. Therapeutic potential of complement modulation. Nat Rev
Drug Discov . 2010;9:43 - 56.
41. Vibhuti A, Gupta K, Subramanian H, Guo Q, Ali H. Distinct and shared roles of beta-
arrestin-1 and beta-arrestin-2 on the regulation of C3a receptor signaling in human
mast cells. PLoS One . 2011;6:e19585.
42. Ahamed J, Haribabu B, Ali H. Cutting edge: differential regulation of chemoattractant
receptor-induced degranulation and chemokine production by receptor phosphoryla-
tion. J Immunol . 2001;167:3559 - 3563.
43. Bamberg CE, Mackay CR, Lee H, et al. The C5a receptor (C5aR) C5L2 is a modulator
of C5aR-mediated signal transduction. J Biol Chem . 2010;285:7633 - 7644.
44. Lattin JE, Greenwood KP, Daly NL, et al. Beta-arrestin 2 is required for complement
C1q expression in macrophages and constrains factor-independent survival. Mol
Immunol . 2009;47:340 - 347.
45. Fong AM, Premont RT, Richardson RM, Yu YR, Lefkowitz RJ, Patel DD. Defective
lymphocyte chemotaxis in beta-arrestin2- and GRK6-deficient mice. Proc Natl Acad Sci
USA . 2002;99:7478 - 7483.
46. Shi Y, Feng Y, Kang J, et al. Critical regulation of CD4 þ T cell survival and autoim-
munity by beta-arrestin 1. Nat Immunol . 2007;8:817 - 824.
47. Wang G, Liu Y, Yang M, et al. Effects of beta-arrestin 2 on cytokine production of
CD4 þ T lymphocytes of mice with allergic asthma. Indian J Exp Biol .

2011;49:585 - 593.
48. Bjorgo E, Solheim SA, Abrahamsen H, et al. Cross talk between phosphatidylinositol
3-kinase and cyclic AMP (cAMP)-protein kinase a signaling pathways at the level of a
protein kinase B/beta-arrestin/cAMP phosphodiesterase 4 complex. Mol Cell Biol .
2010;30:1660- 1672.
49. Bjorgo E, Moltu K, Tasken K. Phosphodiesterases as targets for modulating T-cell
responses. Handb Exp Pharmacol . 2011;204:345 - 363.
50. Abrahamsen H, Baillie G, Ngai J, et al. TCR- and CD28-mediated recruitment of
phosphodiesterase 4 to lipid rafts potentiates TCR signaling. J Immunol . 2004;

173:4847 - 4858.
51. Bjorgo E, Tasken K. Role of cAMP phosphodiesterase 4 in regulation of T-cell func-
tion. Crit Rev Immunol . 2006;26:443 - 451.
52. Baillie GS, Houslay MD. Arrestin times for compartmentalised cAMP signalling and
phosphodiesterase-4 enzymes. Curr Opin Cell Biol . 2005;17:129- 134.
53. von Andrian UH, Mackay CR. T-cell function and migration. Two sides of the same
coin. N Engl J Med . 2000;343:1020 - 1034.
54. Sun Y, Cheng Z, Ma L, Pei G. Beta-arrestin2 is critically involved in CXCR4-
mediated chemotaxis, and this is mediated by its enhancement of p38 MAPK activa-
tion. J Biol Chem . 2002;277:49212 - 49219.
55. Walker JK, Fong AM, Lawson BL, et al. Beta-arrestin-2 regulates the development of
allergic asthma. J Clin Invest . 2003;112:566- 574.
56. Povsic TJ, Kohout TA, Lefkowitz RJ. Beta-arrestin1 mediates insulin-like growth fac-
tor 1 (IGF-1) activation of phosphatidylinositol 3-kinase (PI3K) and anti-apoptosis.
J Biol Chem . 2003;278:51334- 51339.
57. Revankar CM, Vines CM, Cimino DF, Prossnitz ER. Arrestins block G protein-
coupled receptor-mediated apoptosis. J Biol Chem . 2004;279:24578 - 24584.
58. DeFea KA, Vaughn ZD, O'Bryan EM, Nishijima D, Dery O, Bunnett NW. The
proliferative and antiapoptotic effects of substance P are facilitated by formation of a